Premium
Alter als limitierender Faktor in der Itraconazol‐Behandlung der Onychomykose
Author(s) -
Fiallo P.,
Cardo P. P.
Publication year - 2001
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1046/j.1439-0507.2001.00645.x
Subject(s) - itraconazole , medicine , dermatology , cure rate , antifungal , surgery , checklist , pediatrics , biology , paleontology
Summary. A clinical study was carried out involving 24 patients between 18 and 64 years of age with disto‐lateral onychomycosis of finger and/or toenail in whom intermittent therapy with itraconazole was orally administered for 4 months. A follow‐up period of 9 months was instituted to monitor the efficacy of the treatment. Clinical and mycological outcome at the end of the study was correlated with a checklist that included age and sex of the patient, site of infection and species of the causative agent. Nails that were free of disease in both gross and mycological examinations were achieved in 58% of our patients. Age was shown to be the only parameter, among those taken into consideration, that was correlated with the cure rate. The association was found to be statistically significant.